On the other hand, the upregulation of HIPK2 correlates with reduced angiogenesis and impaired wound healing, aggravating diabetic foot ulcers, a condition that can be ameliorated by treatment with miR-221-3p, which targets and inhibits HIPK2. The gene discussed is HIPK2; the disease is diabetic foot.